• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阐明日本福冈县老年血液透析终末期肾病患者结局的变化。

Elucidating variations in outcomes among older end-stage renal disease patients on hemodialysis in Fukuoka Prefecture, Japan.

机构信息

Department of Health Care Administration & Management, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

Health Administration Program, Faculty of Business & Management, Universiti Teknologi MARA, Selangor, Malaysia.

出版信息

PLoS One. 2021 May 25;16(5):e0252196. doi: 10.1371/journal.pone.0252196. eCollection 2021.

DOI:10.1371/journal.pone.0252196
PMID:34033671
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8148375/
Abstract

Variations in health care outcomes and services potentially indicate resource allocation inefficiency. Therefore, this study was conducted to examine variations in mortality and hospitalization cases among end-stage renal disease (ESRD) patients receiving hemodialysis (HD) care from medical facilities located in 13 secondary medical care areas (SMAs) of Fukuoka prefecture, Japan. The research was designed as a retrospective, cross-sectional study using insurance claims data. The subjects of the study were older patients (over 65 years old) insured by the Fukuoka prefecture's Latter-Stage Elderly Healthcare Insurance. Using an electronic claims database, we identified patients with chronic kidney disease (CKD) who had received HD care from April 1, 2017 to March 31, 2018. The CKD status was identified using International Classification of Disease, 10th revision code, and HD maintenance status was ascertained using specific insurance procedure codes. A total of 5,243 patients met our inclusion criteria and their records were subsequently reviewed. About 73% (n = 3,809) of patients had admission records during the period studied. Thus, the data regarding hospital length of stay (LOS) and admission costs were analyzed separately. Significant differences in terms of increased risks in hospitalization were evident in a number of SMAs. An increase in mortality risk due to heart failure and malignancy was observed in two separate SMAs. Also, analyzed LOS, total hospitalization cost, and cost per day according to SMAs showed statistically significant variations. The findings highlight the magnitude of the burden of CKD and ESRD in the community. The high prevalence of ESRD, associated mortality, and hospitalized HD patients signal the need for clinicians to assume broader roles in measures against chronic kidney disease through involvement in community awareness programs. To improve patient outcomes, improvement of regional health care provision, the level of medical care, and the development of existing human resources are needed.

摘要

医疗服务结果和资源分配的差异可能表明效率低下。因此,本研究旨在检查日本福冈县 13 个二级医疗保健区(SMA)的医疗设施为接受血液透析(HD)治疗的终末期肾脏疾病(ESRD)患者的死亡率和住院病例的差异。该研究设计为回顾性、横断面研究,使用保险索赔数据。研究对象为福冈县晚期老年人医疗保险的老年患者(65 岁以上)。我们使用电子索赔数据库,确定了在 2017 年 4 月 1 日至 2018 年 3 月 31 日期间接受 HD 治疗的慢性肾脏病(CKD)患者。CKD 状态使用国际疾病分类第 10 版代码确定,HD 维持状态使用特定的保险程序代码确定。共有 5243 名患者符合纳入标准,随后对其记录进行了审查。约 73%(n=3809)的患者在研究期间有入院记录。因此,分别分析了住院时间(LOS)和入院费用的数据。在多个 SMA 中,住院风险显著增加。两个独立的 SMA 观察到心力衰竭和恶性肿瘤导致的死亡率风险增加。此外,根据 SMA 分析的 LOS、总住院费用和每天费用显示出统计学上的显著差异。研究结果强调了社区中 CKD 和 ESRD 负担的程度。ESRD 的高患病率、相关死亡率和住院 HD 患者表明,临床医生需要通过参与社区意识项目,在预防慢性肾脏病方面发挥更广泛的作用。为了改善患者预后,需要改善区域医疗服务提供、医疗水平和现有人力资源的开发。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91f7/8148375/3ae35ad46fc7/pone.0252196.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91f7/8148375/7d0917db5120/pone.0252196.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91f7/8148375/12ece06741db/pone.0252196.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91f7/8148375/96bd55b8e457/pone.0252196.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91f7/8148375/3ae35ad46fc7/pone.0252196.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91f7/8148375/7d0917db5120/pone.0252196.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91f7/8148375/12ece06741db/pone.0252196.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91f7/8148375/96bd55b8e457/pone.0252196.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91f7/8148375/3ae35ad46fc7/pone.0252196.g004.jpg

相似文献

1
Elucidating variations in outcomes among older end-stage renal disease patients on hemodialysis in Fukuoka Prefecture, Japan.阐明日本福冈县老年血液透析终末期肾病患者结局的变化。
PLoS One. 2021 May 25;16(5):e0252196. doi: 10.1371/journal.pone.0252196. eCollection 2021.
2
Multilevel analysis of hemodialysis-associated infection among end-stage renal disease patients: results of a retrospective cohort study utilizing the insurance claim data of Fukuoka Prefecture, Japan.终末期肾病患者血液透析相关感染的多水平分析:一项利用日本福冈县保险理赔数据的回顾性队列研究结果
Medicine (Baltimore). 2020 May;99(18):e19871. doi: 10.1097/MD.0000000000019871.
3
A contemporary evaluation of carotid endarterectomy outcomes in patients with chronic kidney disease in the United States.美国慢性肾病患者颈动脉内膜切除术疗效的当代评估。
Vascular. 2017 Oct;25(5):459-465. doi: 10.1177/1708538117691430. Epub 2017 Feb 9.
4
Estimation of Prevalence of Kidney Disease Treated With Dialysis in China: A Study of Insurance Claims Data.中国透析治疗的肾脏病患病率估计:一项基于保险理赔数据的研究。
Am J Kidney Dis. 2021 Jun;77(6):889-897.e1. doi: 10.1053/j.ajkd.2020.11.021. Epub 2021 Jan 7.
5
Can dialysis patients be accurately identified using healthcare claims data?能否使用医疗保健理赔数据准确识别透析患者?
Perit Dial Int. 2014 Sep-Oct;34(6):643-51. doi: 10.3747/pdi.2012.00328. Epub 2014 Feb 4.
6
Previously-initiated hemodialysis as prognostic factor for in-hospital mortality in pneumonia patients with stage 5 chronic kidney disease: Retrospective database study of Japanese hospitals.既往开始的血液透析作为 5 期慢性肾脏病合并肺炎患者院内死亡率的预后因素:日本医院的回顾性数据库研究。
PLoS One. 2019 Feb 28;14(2):e0213105. doi: 10.1371/journal.pone.0213105. eCollection 2019.
7
Characterizing hospitalizations of end-stage renal disease patients on dialysis and inpatient utilization of erythropoiesis-stimulating agent therapy.描述透析治疗的终末期肾病患者的住院情况和红细胞生成刺激剂治疗的住院利用情况。
Ann Pharmacother. 2010 Jan;44(1):43-9. doi: 10.1345/aph.1M429. Epub 2009 Dec 22.
8
[REIN Report 2011--summary].[2011年肾脏疾病改善全球结果(KDIGO)报告——摘要]
Nephrol Ther. 2013 Sep;9 Suppl 1:S3-6. doi: 10.1016/S1769-7255(13)70036-1.
9
Burden of kidney disease on the discrepancy between reasons for hospital admission and death: An observational cohort study.肾病负担与住院和死亡原因差异的关系:一项观察性队列研究。
PLoS One. 2021 Nov 3;16(11):e0258846. doi: 10.1371/journal.pone.0258846. eCollection 2021.
10
Different peptic ulcer bleeding risk in chronic kidney disease and end-stage renal disease patients receiving different dialysis.不同透析方式的慢性肾脏病和终末期肾病患者发生消化性溃疡出血的风险不同。
Dig Dis Sci. 2014 Apr;59(4):807-13. doi: 10.1007/s10620-013-2973-6. Epub 2013 Dec 8.

引用本文的文献

1
What is quality in long covid care? Lessons from a national quality improvement collaborative and multi-site ethnography.长期新冠护理中的质量是什么?来自全国质量改进协作和多地点人种志研究的经验教训。
BMC Med. 2024 Apr 15;22(1):159. doi: 10.1186/s12916-024-03371-6.

本文引用的文献

1
Cost-Sharing Effects on Hospital Service Utilization Among Older People in Fukuoka Prefecture, Japan.日本福冈县老年人的医院服务利用的费用分担效应。
Int J Health Policy Manag. 2022 Apr 1;11(4):489-497. doi: 10.34172/ijhpm.2020.190.
2
Physician Distribution by Specialty and Practice Setting: Findings in Japan in 2000, 2010 and 2016.医师专业分布与执业环境:2000、2010 和 2016 年日本的调查结果。
Tohoku J Exp Med. 2020 May;251(1):1-8. doi: 10.1620/tjem.251.1.
3
Multilevel analysis of hemodialysis-associated infection among end-stage renal disease patients: results of a retrospective cohort study utilizing the insurance claim data of Fukuoka Prefecture, Japan.
终末期肾病患者血液透析相关感染的多水平分析:一项利用日本福冈县保险理赔数据的回顾性队列研究结果
Medicine (Baltimore). 2020 May;99(18):e19871. doi: 10.1097/MD.0000000000019871.
4
Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.全球、区域和国家慢性肾脏病负担,1990-2017 年:2017 年全球疾病负担研究的系统分析。
Lancet. 2020 Feb 29;395(10225):709-733. doi: 10.1016/S0140-6736(20)30045-3. Epub 2020 Feb 13.
5
Bring More Data!-A Good Advice? Removing Separation in Logistic Regression by Increasing Sample Size.带来更多数据!—一个好建议?通过增加样本量消除逻辑回归中的分离。
Int J Environ Res Public Health. 2019 Nov 22;16(23):4658. doi: 10.3390/ijerph16234658.
6
Validation of claims data to identify death among aged persons utilizing enrollment data from health insurance unions.利用健康保险联盟的参保数据验证索赔数据以识别老年人的死亡情况。
Environ Health Prev Med. 2019 Nov 23;24(1):63. doi: 10.1186/s12199-019-0819-3.
7
US Renal Data System 2019 Annual Data Report: Epidemiology of Kidney Disease in the United States.美国肾脏数据系统2019年年报:美国肾脏疾病流行病学
Am J Kidney Dis. 2020 Jan;75(1 Suppl 1):A6-A7. doi: 10.1053/j.ajkd.2019.09.003. Epub 2019 Nov 5.
8
Health Inequalities Among Elderly Type 2 Diabetes Mellitus Patients in Japan.日本老年 2 型糖尿病患者的健康不平等。
Popul Health Manag. 2020 Jun;23(3):264-270. doi: 10.1089/pop.2019.0141. Epub 2019 Oct 29.
9
New measures against chronic kidney diseases in Japan since 2018.自 2018 年以来日本针对慢性肾脏病的新措施。
Clin Exp Nephrol. 2019 Nov;23(11):1263-1271. doi: 10.1007/s10157-019-01786-7. Epub 2019 Sep 9.
10
Forecasting maldistribution of human resources for healthcare and patients in Japan: a utilization-based approach.预测日本医疗保健人力资源和患者的分布不均:一种基于利用的方法。
BMC Health Serv Res. 2019 Sep 9;19(1):653. doi: 10.1186/s12913-019-4470-x.